| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/13/2006 | US20060154907 Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 07/13/2006 | US20060154871 Peptides |
| 07/13/2006 | US20060154339 Novel clock gene BMAL2 |
| 07/13/2006 | US20060154295 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy |
| 07/13/2006 | US20060153938 Eye -Rinse Solution Made of Grape juice |
| 07/13/2006 | US20060153925 Novel solid pharmaceutical composition comprising amisulpride |
| 07/13/2006 | US20060153912 Choline ascorbate formulations |
| 07/13/2006 | US20060153877 Remedies for dissease with hypermyotonia |
| 07/13/2006 | US20060153825 Use of protein histidine phosphatase |
| 07/13/2006 | US20060153779 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
| 07/13/2006 | US20060151899 Process for producing drug ultramicroparticle and apparatus therefor |
| 07/13/2006 | DE102004063797A1 Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide Oxygen-containing fused phenylpiperazine and Phenyldiazepancarboxamide |
| 07/13/2006 | DE102004063754A1 Use of a calcitonin gene related peptide antagonist and a serotonin reuptake inhibitor to treat headaches, migraine and cluster headaches |
| 07/13/2006 | DE102004063753A1 Verwendung ausgewählter CGRP-Antagonisten in Kombination mit anderen Arzneistoffen gegen Migräne für die Behandlung von Migräne Use of selected CGRP antagonists in combination with other drugs for migraine for the treatment of migraine |
| 07/13/2006 | DE102004063494A1 Antikörper Antibody |
| 07/13/2006 | CA2596393A1 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions |
| 07/13/2006 | CA2594433A1 Compositions comprising the 2s,4r ketoconazole enantiomer for treating diabetes, metabolic syndrome and other conditions |
| 07/13/2006 | CA2594404A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | CA2594347A1 Tricyclic d-opioid modulators |
| 07/13/2006 | CA2594260A1 Benzoyl-tetrahydropyridine as glyt-1 inhibitors |
| 07/13/2006 | CA2594096A1 Use of selected cgrp antagonists in combination with other antimigraine medical substances for the treatment of migraine |
| 07/13/2006 | CA2593463A1 [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 07/13/2006 | CA2593453A1 Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 07/13/2006 | CA2593432A1 Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 07/13/2006 | CA2593266A1 Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| 07/13/2006 | CA2593209A1 Use of certain phenyl napthyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (ms) |
| 07/13/2006 | CA2593110A1 Methods for the treatment of lysosomal storage disorders |
| 07/13/2006 | CA2593097A1 Use of certain phenyl-naphthyl compounds that do not have significant affintiy to er alpha or beta for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis |
| 07/13/2006 | CA2593044A1 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 07/13/2006 | CA2592771A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | CA2592552A1 Use of certain biphenyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (ms) |
| 07/13/2006 | CA2592543A1 Use of selected compounds for protection of neurones and oligodendrocytes in the treatment of multiple sclerosis |
| 07/13/2006 | CA2592455A1 Substituted 2-amino-quinazolin-4-cn compounds for use in the treatment of cns disorders, pain, stroke, addiction and epilepsy, their preaparation and use as intermediates |
| 07/13/2006 | CA2576332A1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists |
| 07/12/2006 | EP1679316A1 Stable vitamin b6 derivative |
| 07/12/2006 | EP1679313A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 07/12/2006 | EP1679309A1 Antistress drug and medical use thereof |
| 07/12/2006 | EP1679299A1 Compounds for the treatment of diseases associated with the formation of amyloid fibrils |
| 07/12/2006 | EP1679081A2 Therapeutic application of cephaibols |
| 07/12/2006 | EP1679080A2 Prevention and treatment of amyloidogenic disease |
| 07/12/2006 | EP1679075A1 Transdermal preparations and method for relieving side effects in pergolide therapy |
| 07/12/2006 | EP1679073A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(imino-heterocyclyl)-phenyl-amide derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
| 07/12/2006 | EP1679059A2 Utilization of vinpocetine to avoid complications in particular those associated to hearing which occur with epilepsy, and treatment thereof |
| 07/12/2006 | EP1678498A2 Method for determining the antiradical defense potential and use thereof, in particular in veterinary and human preventive therapeutics |
| 07/12/2006 | EP1678180A1 Substituted 2h- 1,2,4 triazolo 4,3-a pyrazines as gsk-3 inhibitors |
| 07/12/2006 | EP1678173A2 4-heterobicyclylamino-substituted quinazolines and analogues thereof as capsaicin-antagonists |
| 07/12/2006 | EP1678159A2 Thiophene-2-carboxamide derivatives and use thereof as cannabinoid cb-1 receptor antagonists |
| 07/12/2006 | EP1677801A1 Triterpene compounds which are effective on improvement of brain function |
| 07/12/2006 | EP1677791A2 Nitrogen-containing fused heterocyclic compounds |
| 07/12/2006 | EP1677787A1 Combinations of potassium channel openers and sodium channel inhibitors or active substances influencing sodium channels in order to treat painful conditions |
| 07/12/2006 | EP1677782A2 Inhibitors of cathepsin s |
| 07/12/2006 | EP1677768A2 Extended release formulations of opioids and method of use thereof |
| 07/12/2006 | EP1677767A2 Crystalline form of gamma-aminobutyric acid analog |
| 07/12/2006 | EP1677737A2 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
| 07/12/2006 | EP1430055B1 7-tert-butyl-3-(2-fluorophenyl)-6-(2h-¬1,2,4|triazol-3-ylmethoxy)-¬1,2,4|triazolo¬4,3-b|pyridazine for the treatment of anxiety and convulsions |
| 07/12/2006 | EP1392311B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 07/12/2006 | EP1338604B1 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | EP1303499B1 Tetrazole derivatives |
| 07/12/2006 | EP1121439B1 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2006 | EP1121157B1 A novel component in the hedgehog signalling pathway |
| 07/12/2006 | EP1023074B1 Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 07/12/2006 | EP0900235B1 Fragments of cr1 and their use |
| 07/12/2006 | EP0788359B1 Combination of dextromethorphan with quinidine or quinine sulfate for treating a variety of intractable disorders |
| 07/12/2006 | CN1802377A Tricyclic compound |
| 07/12/2006 | CN1802376A Cgrp受体拮抗剂 Cgrp receptor antagonists |
| 07/12/2006 | CN1802368A Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
| 07/12/2006 | CN1802367A Imidazole derivatives as glutmate receptor antagonists |
| 07/12/2006 | CN1802357A Aminopyrimidine derivatives and their medical use |
| 07/12/2006 | CN1802351A Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 07/12/2006 | CN1802170A Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 07/12/2006 | CN1802161A Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof |
| 07/12/2006 | CN1802155A Neurocyte protective agent |
| 07/12/2006 | CN1800213A Peptides |
| 07/12/2006 | CN1800186A Adenosine a2a receptor antagonists |
| 07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
| 07/12/2006 | CN1800177A Reduced aminate of geniposide huperzine A and its preparation method and uses |
| 07/12/2006 | CN1800176A Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 07/12/2006 | CN1800145A Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 07/12/2006 | CN1799629A Self-assembled luminous current-conducting nano medicine crystal and ultra-thin film and preparation method thereof |
| 07/12/2006 | CN1799622A Mind-tranquilizing brain-replenishing soft capsule, its preparation process and quality control method |
| 07/12/2006 | CN1799610A Bone-strengthening herbal medicinal wine and its preparation method |
| 07/12/2006 | CN1799609A Soft capsule formulation containing gastrodia tuber medicinal composition and preparation method thereof |
| 07/12/2006 | CN1799589A Smoking stopping method |
| 07/12/2006 | CN1799586A Cold treating capsule and its preparation method |
| 07/12/2006 | CN1799574A Anti-depression formulations |
| 07/12/2006 | CN1799573A Collection of insomnia treatment fresh peanut leaf and method for preparing Chinese proprietary medicine thereby |
| 07/12/2006 | CN1799570A Drug addiction stopping medicine and preparation method thereof |
| 07/12/2006 | CN1799564A Application of valeriana wallichii and its extract in preparation of medicine for treating anxiety neurosis |
| 07/12/2006 | CN1799556A Anti-drowsiness aromatic agent |
| 07/12/2006 | CN1799552A Single sialic acid tetrahexose ganglioside preparation method |
| 07/12/2006 | CN1799428A Alcohol free spirit |
| 07/12/2006 | CN1799414A Health-caring, low cholesterol egg with antioxidant, presenile dementia preventing functions |
| 07/12/2006 | CN1263760C Novel buprenorphine ester derivatives and process for preparing the same and medical composition with long-acting analgesic effect |
| 07/12/2006 | CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 07/12/2006 | CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives |
| 07/12/2006 | CN1263755C Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 07/12/2006 | CN1263751C Novel compounds |